Table 4.
Risk factors associated with severe-critically illness development.
Univariate analysis | Multivariate logistic regression analysis | |||||
Variables | P value | OR | 95% CI | P value | OR | 95% CI |
Age | <.001 | 11.43 | 7.96–14.91 | .004 | 1.08 | 1.03–1.14 |
Shortness of breath | <.001 | 5.97 | 3.16–9.91 | .250 | ||
Bilateral involved | <.001 | 2.04 | 1.32–3.16 | .472 | ||
Lymphocytes | .022 | 0.46 | 0.12–0.79 | .034 | 0.28 | 0.04–0.88 |
Hemoglobin | .026 | 9.37 | 1.15–17.59 | .597 | ||
Platelet | .001 | 5.29 | 2.66–9.63 | .073 | ||
ALT | .003 | 1.53 | 3.66–17.39 | .507 | ||
AST | <.001 | 1.12 | 6.32–13.92 | .317 | ||
LDH | <.001 | 5.76 | 2.70–6.81 | .085 | ||
Albumin | <.001 | 5.27 | 3.78–6.76 | .355 | ||
CRP | <.001 | 4.31 | 2.08–6.53 | .823 | ||
ESR | <.001 | 2.11 | 1.46–4.75 | .209 | ||
PT | .020 | 1.45 | 1.25–1.85 | .424 | ||
D-dimer | .006 | 4.43 | 1.61–8.46 | .024 | 3.21 | 1.39–7.40 |
Fibrinogen | <.001 | 1.46 | 1.11–1.75 | .613 | ||
Hypertension | .002 | 2.18 | 1.31–3.64 | .504 | ||
Diabetes | <.001 | 4.26 | 2.44–7.48 | .104 | ||
COPD | .006 | 4.45 | 1.64–12.03 | .703 | ||
Coronary heart disease | .033 | 3.12 | 1.14–8.56 | .258 | ||
Cerebrovascular disease | .008 | 6.25 | 1.77–22.09 | .578 | ||
Cancer | .001 | 9.52 | 2.63–34.49 | .061 |